: : : 2007-04-30 to 2007-05-06
Bayer Discontinues Trasylol Clinical Trial Program In Non-CABG Indications
April 30, 2007 10:53
Bayer HealthCare has decided to end three ongoing clinical studies investigating the safety and efficacy of Trasylol on transfusion requirements and blood loss in adults undergoing elective spinal fusion surgery, pneumonectomy or esophagectomy for cancer,... (Read Article)
